Nevada Coalition for Psychedelic Medicines
Public records raise at least one point you should look into before giving.
What it says it does
To champion the legalization of psychedelic-assisted therapy and the reduction of penalties. Through education, collaboration, cultural change, and policy reform, we are fighting to save lives and revolutionize mental health.
- Income
- $296,353
- Spending
- $191,808
- Employees
- 0
- Volunteers
- 20
- Highest pay
- $77,000, ceo/president
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Governance
This return does not answer enough of the governance questions to score.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (2)
- $74,032 spent. Legislative Advocacy & Policy Reform:NCPM advocates for legislation and policy reforms that expand access to psychedelic-assisted therapies, particularly for veterans, first responders, and others with treatment-resistant conditions. In 2024, we engaged directly with Nevada legislators, testified at hearings, coordinated with national advocacy partners, and organized public awareness efforts to support safe and regulated access to psychedelic therapies.(Continued on Schedule O)Key accomplishments include:- Meeting with Nevada state senators and assembly members to advance psychedelic therapy legislation.- Providing policy recommendations in collaboration with national partners including veteran and law enforcement non-profits. - Building bipartisan support and educating policymakers on the therapeutic potential and public health benefits of psychedelic-assisted therapy.In 2024, NCPM leadership also served on the Nevada Psychedelic Medicines Working Group, established under SB242 (passed in 2023 with NCPM's support). Through this role and sustained interim advocacy, NCPM helped shape key policy recommendations that led to the introduction of two major bills in 2025: SJR10, a resolution urging Congress to reschedule certain psychedelics, allocate funding for research, and expand access to therapy, and AB378, a pilot program providing regulated access to psilocybin therapy for veterans and former first responders. SJR10 passed with bipartisan support, with 27 legislators signing on as sponsors or co-sponsors; AB378 was similarly backed by 24 bipartisan supporters. Throughout the year, NCPM remained committed to its mission to advance safe, equitable, and science-informed psychedelic policy in Nevada.
- $62,949 spent. Public Education and Community Engagement:NCPM advances public understanding about the therapeutic potential of psychedelic medicines through educational outreach and community engagement efforts aimed at shifting public perception, informing policy, and empowering stakeholders. In 2024, we hosted virtual summits and webinars addressing emerging clinical research and state and federal policy developments, published regular newsletters, and distributed educational content on safe, equitable access to psychedelic therapies. These initiatives aimed to inform both the public and policymakers, supporting cultural change and legislative momentum.(Continued on Schedule O)Accomplishments may include:- Produced and distributed digital newsletters highlighting local and national psychedelic policy developments.- Hosted online educational events, including webinars and virtual summits, to inform the public about access models, research, and regulation.- Maintained active engagement across digital platforms, reaching approximately 2,300 followers across email and combined social platforms.- Provided informational resources to policymakers and the public in support of safe, regulated psychedelic-assisted therapies.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(4) social welfare organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.
Are donations tax-deductible? Caution.
The IRS master file records contributions to this 501(c)(4) social welfare organization as not deductible.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since December 2023.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.